CHEMOTHERAPY INDUCED ALOPECIA
Clinical trials for CHEMOTHERAPY INDUCED ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY INDUCED ALOPECIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY INDUCED ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cold cap showdown: which method best saves hair during chemo?
Symptom relief Recruiting nowThis study compares two scalp cooling techniques to prevent hair loss in women receiving chemotherapy for early-stage breast cancer. Researchers will test both a traditional cooling cap and a newer cooling mask to see which works better at preserving hair. They'll also measure ho…
Matched conditions: CHEMOTHERAPY INDUCED ALOPECIA
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Chilling hope: can a cold cap save hair for women battling advanced breast cancer?
Symptom relief Recruiting nowThis study is testing whether a scalp cooling device can help prevent hair loss in people receiving chemotherapy for metastatic breast cancer. About 120 participants will be assigned to either use the cooling cap during their treatment or not, and researchers will compare hair lo…
Matched conditions: CHEMOTHERAPY INDUCED ALOPECIA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Feb 25, 2026 15:08 UTC
-
Scientists test if hair loss gel stays on the scalp or enters blood
Knowledge-focused Recruiting nowThis early study aims to understand how much of a topical gel containing phenylephrine, applied to the scalp to potentially treat chemotherapy hair loss, gets absorbed into the bloodstream. It will involve 24 healthy adult women using the gel daily for three weeks. Researchers wi…
Matched conditions: CHEMOTHERAPY INDUCED ALOPECIA
Phase: EARLY_PHASE1 • Sponsor: Applied Biology, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC